Ledger.Open graph →
SEC Form D · filed December 30, 2025

IN8BIO, INC

Offering
$40.2M
Sold
$20.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Kate R. Rochlin · New York, NYExecJeremy R. Graff · New York, NYDirectorEmily R. Fairbairn · New York, NYDirectorPatrick Mccall · New York, NYExecLuba R. Greenwood · New York, NYDirectorPeter S. Brandt · New York, NYDirectorLawrence R. Lamb · New York, NYExecAlan S. Roemer · New York, NYDirectorWilliam Ho · New York, NYExec · DirectorCorinne R. Epperly · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗